Discrete state analysis for interpretation of data from clinical trials

Medical Care

Volumn 42, Issue 2, 2004, Pages 183-196

  Sugar, Catherine A ^a,d   James, Gareth M ^a   Lenert, Leslie A ^b   Rosenheck, Robert A ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cluster analysis; Cost benefit analysis; Health state models; Longitudinal studies; Schizophrenia

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; GOVERNMENT; HUMAN; METHODOLOGY; PRINCIPAL COMPONENT ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED STATES;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; HALOPERIDOL; HUMANS; MODELS, STATISTICAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRINCIPAL COMPONENT ANALYSIS; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 1442352858     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000108748.13206.ba     Document Type: Article

References (23)

1. Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490-502.
2. Feeny D, Furlong W, Barr RD, et al. The multiattribute approach to the assessment of health-related quality of life: Health Utilities Index. Meet Pediatr Oncol. 1998;Suppl 1:54-59.
3. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-1108.
4. Kind P, Dolan P, Gudex C, et al. Variations in population health status: results from a United Kingdom national questionnaire survey. BW. 1998:316:736-741.
5. Andresen EM, Rothenberg B M, Kaplan RM, et al, Performance of a self-administered mailed version of the Quality of Well-Being (QWB-SA) questionnaire among older adults. Med Care. 1998;36:1349-1360.
6. Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res. 1988;23:203-235.
7. Rosenheck R, Cramer J, Xu W, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med. 1997;337:809-815.
8. Kane JM, Honigfeld G, Singer J, et al. Clozapine for the treatmentresistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
9. Kay SR, Fiszbein A, Opler LA, et al. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13: 261-276.
10. Guy W. Abnormal involuntary movements. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health (DHEW publication no. ADM 76-338); 1976.
11. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672-676.
12. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;Suppl 212:11-19.
13. Seber G. Multivariate Observations. Wiley Series in Probability and Mathematical Statistics. Probability and Mathematical Statistics. New York: Wiley; 1984.
14. Wu AW, Jacobson KL, Frick KD, et al. Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 2002;11:273-282.
15. Hartigan JA, Wong MA. Algorithm AS 136: a k-means clustering algorithm. Applied Statistics. 1978;28:100-108.
16. Sugar CA, Sturm R, Sherboume C, et al. Empirically defined health states for depression from the SF-12. Health Serv Res. 1998;33:911-928.
17. Sugar CA, James GM. Finding the number of clusters in a data set: an information theoretic approach. Journal of the American Statistical Association. 2003;98:750-763.
18. Efron B, Tibshirani R. An Introduction to the Bootstrap. London: Chapman and Hall; 1993.
19. Lenert LA, Sturley AE. Use of the Internet to study the utility values of the public. Proc AMIA Symp. 2002;440-444.
20. Lenert LA, Sturley AE, Rupnow M. Toward improved methods for measurement of utility: automated repair of errors in elicitations. Med Decis Making. 2003;23:67-75.
21. Gold M, Patrick D, Torrance G, et al. Cost-Effectiveness in Health and Medicine. New York: Oxford Press; 1996.
22. Rosenheck R, Cramer J, Xu W, et al. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Health Serv Res. 1998;33:1237-1261.
23. Taylor HM, Karlin S. An Introduction to Stochastic Modeling. San Diego: Academic Press; 1994.